![Linda Grais](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Linda Grais
Directeur/Membre du Conseil chez
CORVUS PHARMACEUTICALS, INC.
Fortune : 841 325 $ au 31/05/2026
Profil
Linda S.
Grais was the founder of Structural Genomix, Inc., founded in 1997, where the title held was Executive Vice President from 1997 to 2004.
Dr. Grais was the founder of SGX Pharmaceuticals, Inc., founded in 1998, where the title held was Executive Vice President from 1998 to 2003.
Current jobs include Independent Director at Corvus Pharmaceuticals, Inc. since 2019; Director at The J.
David Gladstone Institutes; Director at CollectiveHealth, Inc. since 2023; Director at Research Bridge Partners; Director at PartnersGlobal; Independent Non-Executive Director at ICON plc since 2021; and Director at Iolyx Therapeutics, Inc. Former jobs include President, Chief Executive Officer & Director at OCERA Therapeutics LLC from 2012 to 2017; Independent Director at PRA Health Sciences, Inc. from 2015 to 2021; Independent Director at Zosano Pharma Corp.; Independent Director at Deerfield Healthcare Technology Acquisitions Corp.; Independent Director at ARCA biopharma, Inc. from 2007 to 2011; Attorney at Wilson Sonsini Goodrich & Rosati PC from 1993 to 1997; Assistant Clinical Professor at The University of California, San Francisco; and Managing Member & Partner at InterWest Venture Management Co. from 2005 to 2011.
Education includes an undergraduate degree from Yale University conferred in 1979, a doctorate from Yale School of Medicine conferred in 1984, and a graduate degree from Stanford Law School conferred in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ICON PLC 0,01 % | 18/03/2026 | 5 271 ( 0,01 % ) | 717 225 $ | 31/05/2026 |
| 11/06/2026 | 10 000 ( 0,01 % ) | 124 100 $ | 31/05/2026 |
Postes actifs de Linda Grais
| Sociétés | Poste | Début |
|---|---|---|
| CORVUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 28/01/2019 |
| ICON PUBLIC LIMITED COMPANY | Directeur/Membre du Conseil | 01/07/2021 |
Research Bridge Partners /Venture Capital/
 Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Private Equity Investor | - |
CollectiveHealth, Inc.
 CollectiveHealth, Inc. Packaged SoftwareTechnology Services Provides self-insurance platform | Directeur/Membre du Conseil | 11/04/2023 |
PartnersGlobal
 PartnersGlobal Miscellaneous Commercial ServicesCommercial Services Operates as a development and social organization | Directeur/Membre du Conseil | - |
Research Bridge Partners
 Research Bridge Partners Investment ManagersFinance Functions as an alternative investment manager | Directeur/Membre du Conseil | - |
The J. David Gladstone Institutes
 The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Directeur/Membre du Conseil | - |
Anciens postes connus de Linda Grais
| Sociétés | Poste | Fin |
|---|---|---|
| PRA HEALTH SCIENCES, INC. | Directeur/Membre du Conseil | 01/07/2021 |
| OCERA THERAPEUTICS INC | Directeur Général | 01/12/2017 |
| ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Linda Grais
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
PRA Health Sciences, Inc.
 PRA Health Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services for pharmaceutical & biotechnology companies | Commercial Services |
ICON plc
 ICON plc Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Commercial Services |
Corvus Pharmaceuticals, Inc.
 Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs and other pharmaceutical products | Health Technology |
Wilson Sonsini Goodrich & Rosati PC
 Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The J. David Gladstone Institutes
The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Commercial Services |
ARCA biopharma, Inc.
 ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Interwest Venture Management Co.
 Interwest Venture Management Co. Investment ManagersFinance InterWest Venture invests in companies located in the United States. The firm focuses on healthcare and information technology. It participates in early stage transactions. It also acts as a lead investor and takes a seat on the board. | Finance |
Zosano Pharma Corp.
 Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that specializes in the systemic administration of therapeutics | Health Technology |
Structural Genomix, Inc. | |
Stanford Law School
 Stanford Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CollectiveHealth, Inc.
CollectiveHealth, Inc. Packaged SoftwareTechnology Services Provides self-insurance platform | Technology Services |
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Finance |
Deerfield Healthcare Technology Acquisitions Corp.
 Deerfield Healthcare Technology Acquisitions Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Research Bridge Partners
Research Bridge Partners Investment ManagersFinance Functions as an alternative investment manager | Finance |
PartnersGlobal
PartnersGlobal Miscellaneous Commercial ServicesCommercial Services Operates as a development and social organization | Commercial Services |
Choisissez Zonebourse 
